Trinity Biotech (TRIB) Stock: Buy, Sell, or Hold?
TRIB - Trinity Biotech plc
$6.57
-0.15 (-2.26%)
▼
5d:
-11.24%
30d:
-32.15%
90d:
+1589.3%
HOLD
MODERATE Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Get Alerted When TRIB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TRIB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TRIB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TRIB is currently trading at $6.57, which is considered oversold relative to its 30-day fair value range of $7.05 to $9.66.
Technical Outlook: Technically, TRIB is in a strong uptrend. The price is currently testing key support at $6.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $3.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TRIB is in a strong uptrend. The price is currently testing key support at $6.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $3.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.05 -
$9.66
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 55.4% above Wall St target ($3.00)
- NEUTRAL: Bottoming setup forming (53/100) — watch for confirmation
- CAUTION: 5-day price weakness (-11.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$7.05 -
$9.66
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.62
Resistance Level
$7.77
Current Trend
Strong Uptrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.17
Wall Street Target
$3.00
(-55.4%)
Revenue Growth (YoY)
-5.5%
Earnings Growth (YoY)
-77.3%
Profit Margin
-85.4%
Share & Embed Analysis
Last updated: September 29, 2026 10:52 AM ET
Data refreshes hourly during market hours. Next update: 11:52 AM
Data refreshes hourly during market hours. Next update: 11:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRIB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 72 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 48 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 55 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 60 HOLD |